Search

Search Constraints

You searched for: Author/Creator Planchard, D.

Search Results

11. LBA51Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC). (18th September 2017)

12. Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms. (October 2020)

14. Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria. (January 2018)

17. PV-0208 Immune-related pneumonitis in NSCLC patients treated with ICI: impact of previous thoracic RT. (April 2019)